הליקסט FS 1000 IU ישראל - עברית - Ministry of Health

הליקסט fs 1000 iu

mediline ltd. - factor viii recombinant 1000 iu/dose - lyophilized powder for injection - coagulation factor viii - for the treatment of classical hemophilia ( hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor viii.

אימונאט 250 IU ישראל - עברית - Ministry of Health

אימונאט 250 iu

teva medical marketing ltd. - factor viii human coagulation 250 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.

אימונאט 500 IU ישראל - עברית - Ministry of Health

אימונאט 500 iu

teva medical marketing ltd. - factor viii human coagulation vhsd treated 500 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.

אימונאט 1000 IU ישראל - עברית - Ministry of Health

אימונאט 1000 iu

teva medical marketing ltd. - factor viii human coagulation 1000 iu/vial - powder for solution for injection - coagulation factor viii - treatment and prophylaxis of bleeding in patients with congenital (haemophilia a) or acquired factor viii deficiency. von willebrand's disease with factor viii deficiency.

קובאלטרי IU 1000 ישראל - עברית - Ministry of Health

קובאלטרי iu 1000

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 1000 iu - coagulation factor viii

קובאלטרי IU 2000 ישראל - עברית - Ministry of Health

קובאלטרי iu 2000

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 2000 iu - coagulation factor viii

קובאלטרי IU 250 ישראל - עברית - Ministry of Health

קובאלטרי iu 250

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 250 iu - coagulation factor viii

קובאלטרי IU 500 ישראל - עברית - Ministry of Health

קובאלטרי iu 500

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 500 iu - coagulation factor viii

קוג'נייט FS 250 IU ישראל - עברית - Ministry of Health

קוג'נייט fs 250 iu

bayer israel ltd - antihemophilic factor (recombinant) sucrose 250 iu/vial - powder for solution for injection - blood coagulation factors - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor viii.routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with severe hemophilia a with no pre-existing joint damage.kogenate fs is not indicated for the treatment of von willebrand’s disease.

רקומבינאט IU 250 ישראל - עברית - Ministry of Health

רקומבינאט iu 250

teva medical marketing ltd. - coagulation factor viii recombinant 250 iu/vial - powder for solution for injection - coagulation factor viii - the use of recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).recombinate is also indicated in the perioperative management of patients with haemophilia a. recombinate is appropriate for use in children of all ages including the newborn. (safety and efficacy studies have been performed in both previously treated and previously untreated children). the product in not suitable for the treatment of von willebrand's disease.